Cargando…
Treatment of Infected Hip Arthroplasty
The clinical outcomes of a consecutive series of deep total joint infections treated with a prosthesis retaining protocol were reviewed. The treatment of deep periprosthetic joint infections is challenging. In recent years, two-stage exchange arthroplasty has emerged as the gold standard for success...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864510/ https://www.ncbi.nlm.nih.gov/pubmed/20448834 http://dx.doi.org/10.2174/1874325001004010126 |
_version_ | 1782180784155656192 |
---|---|
author | Hernigou, Philippe Flouzat-Lachianette, C.-H. Jalil, R. Uirassu Batista, Sobrinho Guissou, I. Poignard, A. |
author_facet | Hernigou, Philippe Flouzat-Lachianette, C.-H. Jalil, R. Uirassu Batista, Sobrinho Guissou, I. Poignard, A. |
author_sort | Hernigou, Philippe |
collection | PubMed |
description | The clinical outcomes of a consecutive series of deep total joint infections treated with a prosthesis retaining protocol were reviewed. The treatment of deep periprosthetic joint infections is challenging. In recent years, two-stage exchange arthroplasty has emerged as the gold standard for successful elimination of infection. With success rates averaging 82% to 96%, this treatment method has both the highest and most consistent rate of infection eradication. Another alternative in the treatment of the deep periprosthetic infection is the single-stage exchange arthroplasty. Successful eradication of infection after single-stage exchange arthroplasty has been reported to average from 60% to 83% after total hip infections. While both the single and two-stage exchange arthroplasty are viable treatment options, they are associated with negative factors such as they are time consuming, expensive, and may entail a 6- to 12-week period with a minimally functioning extremity after prosthesis removal. This paper reports the general principles of management, the treatment of acute infection occurring in the postoperative period or later, and the treatment of chronic infection by exchange arthroplasty or resection arthroplasty. |
format | Text |
id | pubmed-2864510 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Bentham Open |
record_format | MEDLINE/PubMed |
spelling | pubmed-28645102010-05-06 Treatment of Infected Hip Arthroplasty Hernigou, Philippe Flouzat-Lachianette, C.-H. Jalil, R. Uirassu Batista, Sobrinho Guissou, I. Poignard, A. Open Orthop J Article The clinical outcomes of a consecutive series of deep total joint infections treated with a prosthesis retaining protocol were reviewed. The treatment of deep periprosthetic joint infections is challenging. In recent years, two-stage exchange arthroplasty has emerged as the gold standard for successful elimination of infection. With success rates averaging 82% to 96%, this treatment method has both the highest and most consistent rate of infection eradication. Another alternative in the treatment of the deep periprosthetic infection is the single-stage exchange arthroplasty. Successful eradication of infection after single-stage exchange arthroplasty has been reported to average from 60% to 83% after total hip infections. While both the single and two-stage exchange arthroplasty are viable treatment options, they are associated with negative factors such as they are time consuming, expensive, and may entail a 6- to 12-week period with a minimally functioning extremity after prosthesis removal. This paper reports the general principles of management, the treatment of acute infection occurring in the postoperative period or later, and the treatment of chronic infection by exchange arthroplasty or resection arthroplasty. Bentham Open 2010-03-02 /pmc/articles/PMC2864510/ /pubmed/20448834 http://dx.doi.org/10.2174/1874325001004010126 Text en © Hernigou et al.; Licensee Bentham Open. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Hernigou, Philippe Flouzat-Lachianette, C.-H. Jalil, R. Uirassu Batista, Sobrinho Guissou, I. Poignard, A. Treatment of Infected Hip Arthroplasty |
title | Treatment of Infected Hip Arthroplasty |
title_full | Treatment of Infected Hip Arthroplasty |
title_fullStr | Treatment of Infected Hip Arthroplasty |
title_full_unstemmed | Treatment of Infected Hip Arthroplasty |
title_short | Treatment of Infected Hip Arthroplasty |
title_sort | treatment of infected hip arthroplasty |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864510/ https://www.ncbi.nlm.nih.gov/pubmed/20448834 http://dx.doi.org/10.2174/1874325001004010126 |
work_keys_str_mv | AT hernigouphilippe treatmentofinfectedhiparthroplasty AT flouzatlachianettech treatmentofinfectedhiparthroplasty AT jalilr treatmentofinfectedhiparthroplasty AT uirassubatistasobrinho treatmentofinfectedhiparthroplasty AT guissoui treatmentofinfectedhiparthroplasty AT poignarda treatmentofinfectedhiparthroplasty |